To characterize the leukemogenicity of the Brca1 and Trp53 deficiency–associated hematopoietic neoplasm and to identify leukemia-initiating cells (LICs), we carried out transplantation experiments. This evidence concerns the gene BRCA1 and hematopoietic and lymphoid cell neoplasm.